The potential health benefits of the ketogenic diet: a narrative review

K Dowis, S Banga - Nutrients, 2021 - mdpi.com
Considering the lack of a comprehensive, multi-faceted overview of the ketogenic diet (KD)
in relation to health issues, we compiled the evidence related to the use of the ketogenic diet …

Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

AJ Klil-Drori, L Azoulay, MN Pollak - Nature reviews Clinical oncology, 2017 - nature.com
The prevalence of obesity, of type 2 diabetes mellitus (T2DM), and of cancer are all
increasing globally. The relationships between these diseases are complex, and thus …

[HTML][HTML] Combination of hypoglycemia and metformin impairs tumor metabolic plasticity and growth by modulating the PP2A-GSK3β-MCL-1 axis

M Elgendy, M Ciro, A Hosseini, J Weiszmann… - Cancer cell, 2019 - cell.com
Tumor cells may adapt to metabolic challenges by alternating between glycolysis and
oxidative phosphorylation (OXPHOS). To target this metabolic plasticity, we combined …

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial

S Kordes, MN Pollak, AH Zwinderman… - The lancet …, 2015 - thelancet.com
Background In preclinical work and retrospective population studies, the anti-diabetic drug
metformin has been associated with antineoplastic activity and decreased burden of many …

Targeting cancer metabolism: dietary and pharmacologic interventions

C Vernieri, S Casola, M Foiani, F Pietrantonio… - Cancer discovery, 2016 - AACR
Most tumors display oncogene-driven reprogramming of several metabolic pathways, which
are crucial to sustain their growth and proliferation. In recent years, both dietary and …

Obesity and cancer: mechanistic insights from transdisciplinary studies

EH Allott, SD Hursting - Endocrine-related cancer, 2015 - erc.bioscientifica.com
Obesity is associated with a range of health outcomes that are of clinical and public health
significance, including cancer. Herein, we summarize epidemiologic and preclinical …

Metabolic features of cancer stem cells: the emerging role of lipid metabolism

R Mancini, A Noto, ME Pisanu, C De Vitis… - Oncogene, 2018 - nature.com
Cancer stem cells (CSCs) are an uncommon subset of tumor cells capable of self-renewal,
differentiating, and recreating the parental tumor when transplanted into the murine …

Therapeutic repurposing of biguanides in cancer

H Zhao, KD Swanson, B Zheng - Trends in cancer, 2021 - cell.com
Biguanides are a class of antidiabetic drugs that includes phenformin and metformin;
however, the former was withdrawn from approval in many countries due to its toxicity …

Obesity, type-2 diabetes and cancer: mechanistic insights

K Kashfi, CL Rosen, M Aslan - Critical Reviews™ in …, 2019 - dl.begellhouse.com
Obesity leads to many diseases including hypercholesterolemia, type-2 diabetes,
hypertension, cardiovascular disease, and cancer. It is the fastest-growing lethal disease in …

Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy

S Verdura, E Cuyàs, B Martin-Castillo… - …, 2019 - Taylor & Francis
The development of a single immuno-metabolic adjuvant capable of modulating, in the
appropriate direction and intensity, the complex antagonistic and symbiotic interplays …